De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival.

Saved in:
Bibliographic Details
Title: De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival.
Authors: Mittelbronn, M.1 michel-guy-andr.mittelbronn@med.uni-tuebingen.de, Capper, D.1, Bunz, B.1, Dietz, K.2, Goeppert, B.1, Ajaaj, R.3, Tabatabai, G.4, Stubenvoll, F.5, Schlaszus, H.1, Merseburger, A. S.6, Becker, R.3, Freudenstein, D.5, Wick, W.4, Weller, M.4, Meyermann, R.1, Simon, P.7
Source: Neuropathology & Applied Neurobiology. Jun2007, Vol. 33 Issue 3, p299-307. 9p.
Database: Academic Search Ultimate
Description
ISSN:03051846
DOI:10.1111/j.1365-2990.2006.00820.x